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Stem cellsThe thyroid hormones control the development and the homeostasis of several organs in vertebrates. Their
actions depend, for the most part, on nuclear receptors, the TRs, which are transcription factors whose activity
is modulated by the hormone T3. The gastrointestinal tract is a well characterized target of thyroid hormones
and TRs, as extensively described in the literature. In fact, its remodeling in amphibians during thyroid
hormone-dependent metamorphosis is well characterized at the cellular and the molecular levels. However,
whereas a great attention has been paid to the nervous system and to cardiac development and physiology, the
function of thyroid hormones and TRs in the mammalian gastrointestinal tract has been, until recently,
underestimated. Several studies have described an important conservation of this hormonal signal during
intestinal development and have suggested that it may play a role in stem cell physiology in both amphibians
and mammals. These ﬁndings show the importance of the thyroid hormones and TRs, whose homologous
actions aremaintained across species. In the present review, we summarize themost recent data on this issue,
starting from work that has been conducted on amphibian metamorphosis to results on postnatal
development, homeostasis, and tumorigenesis in mammals. This article is part of a Special Issue entitled:
Translating nuclear receptors from health to disease.slating nuclear receptors from
33 472728080.
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1.1. Thyroid hormone synthesis and metabolism
The synthesis of thyroid hormones (THs) is regulated through the
hypothalamus–pituitary–thyroid axis [1] (Fig. 1). The follicular cells of
the thyroid gland synthesize and secrete L-thyroxine, or T4, and 3,5,3′-
L-triiodothyronine, or T3. This process is under the control of the
circulating TH levels through negative feedback loops of this axis [1].
In most vertebrates, the predominant hormone produced by the
thyroid gland is T4. This hormone is transported by the blood to the
peripheral organs, where it is deiodinated by types I and II T4-5′-
deiodinases. The loss of one iodine atom allows the synthesis of T3,
which is considered the active hormone because of its binding to the
nuclear receptor TR [2]. The liver and the kidney are the principal
organs responsible for T4 deiodination and the synthesis of T3, which
accounts for up to two-thirds of T3 production and release into the
blood. However, most of the organs and tissues are also efﬁcient in
producing T3, as discussed below [3].The intracellular concentration of T3 is dependent upon the uptake
of T3 and T4 and their subsequent metabolism [4]. Both of these
hormones are actively transported across the cell membrane by
speciﬁc transporter proteins, of which, monocarboxylate transporter-
8 and organic anion-transporting polypeptide-1c are the best
characterized [5–8]. Three iodothyronine deiodinase selenoenzymes
(D1, D2, and D3) regulate TH activation and catabolism [4]. As
mentioned previously, D1 and D2 catalyze the 5′-deiodination of T4 to
its active metabolite T3. In particular, the action of D1 provides the
main source of circulating T3, whereas D2 is the isoenzyme that is
primarily responsible for the local production of T3 in the target cells.
T3 that is derived from D2 activity in the skeletal muscle may also
contribute to the circulating levels of T3. Conversely, D3 catalyzes the
irreversible 5-deiodination of T4 and T3 to their inactive metabolites
rT3 (3,5,5′-T3, or reverse T3) and 3,3′-T2 and protects the target cells
from an excess of THs. Altogether, these mechanisms that are related
to TH uptake andmetabolism determine the levels of T3 availability in
cells [4].
1.2. The thyroid hormone nuclear receptors
The thyroid hormone receptors (TRs) are transcription factors that
belong to the nuclear receptor superfamily [9]. The main character-
istic of the TRs is the presence of a DNA- and a hormone-binding
domain, known as DBD and HBD, respectively (Fig. 2). The amino-acid
sequence of these domains is highly conserved across species [10].
Fig. 1. Regulation of thyroid hormone synthesis. The picture shows the complex
hypothalamus–pituitary–thyroid regulatory loop. TSH stimulates TH synthesis in the
thyroid. Increased levels of circulating TH repress TRH and TSH expression, maintaining
unaltered levels of circulating hormones.
Fig. 2. Representation of the various isoforms encoded by TRα (A) or TRβ (B) genes. The
pictures show the different domains involved in TR function. These include the DBD and
HBD that are speciﬁcally present in the TRα1, TRβ1, TRβ2, and TRβ3 proteins, bona ﬁde
T3 nuclear receptors (bold). TRα2 and the truncated TRΔ isoforms lack each or both
domains. Other functional regions of the TRs include cofactor-binding domains (located
in A/B, D, and E) and dimerization domains (located in C and E). AF-1 and AF-2 domains
are important for transcriptional activation.
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hormone-binding and for interaction with co-regulators [10]. Acti-
vating function 1 and activating function 2, which are located at the
amino-terminal and carboxy-terminal ends, respectively, are respon-
sible for the hormone-independent or hormone-dependent transac-
tivation properties of the receptors [12]. The amino-terminal end also
contains a sequence for nuclear localization (NLS) [13].
The TRs bind speciﬁc DNA sequences named thyroid hormone
response elements (TREs), which are generally located within the
genomic non-coding regions of the target genes. The canonical TRE
consensus is a tandem of AGGT(C/A) sequences in direct repetition
that are separated by four base pairs, named the direct repeat 4 (DR4)
[14]. However, the TREs that are present in the promoters of the target
genes often differ from the consensus sequences in terms of their
arrangements as palindromes or inverted palindromes or in the
number of nucleotides that separate the tandem sequences [15]. The
existence of this variety of TREs may help explain the different
modalities of transcriptional modulation by TRs (i.e., activation vs.
repression) [14].
The characteristics summarized in this paragraph refer to the TRs
in mammals, but their peculiarities are conserved in the phyla and
genera for which they have been described. In fact, genome-wide
analyses have revealed that TRs are not unique to chordates because
orthologous genes are present in platyhelminths and molluscs. Until
now, no TR orthologs had been identiﬁed in Porifera or Cnidaria. A
detailed analysis of the gene structure and the function of the TRs in
invertebrates is reported by Wu et al. [16]. The authors presented
an interesting overview of TR functionality (in silico and in vitro)
but gave very little information about their expression patterns. TRs
have also been described in the cephalochordate amphioxus [17]
and in non-mammalian vertebrate species, such as salamanders
[18], crocodiles [19], gold ﬁsh [20], salmon [21], and amphibians
[22,23].
Due to tetraploidy, there are four TR genes in Xenopus: two TRα
genes and two TRβ genes. Alternative splicing of the TRβ transcripts
gives rise to two different isoforms for each TRβ gene [24]. Two genes
in mammals encode for the T3 nuclear receptors: TRα and TRβ [14].
Each gene generates different proteins using different promoters and/
or alternative splicing (Fig. 2, [2,14]). The TRα locus codes for four
isoforms (Fig. 2A), but only TRα1 can bind both T3 and DNA [14,25].TRα1 and TRα2 result from the alternative splicing of a primary
transcript [26]. TRΔα1 and TRΔα2 result from the alternative splicing
of a secondary transcript, starting from an internal promoter that is
located in the intron 7 [27]. Previous studies have shown that TRα2,
TRΔα1, and TRΔα2 behave as antagonists of TRα1 on its target genes
through a mechanism that has not yet been characterized [26–28].
TRα1 and TRα2 have a widespread, ubiquitous expression, whereas
the short TRΔα1 and TRΔα2 isoforms display restricted expression
patterns [29]. The TRβ locus codes for four isoforms (Fig. 2B),
including three receptors, TRβ1, TRβ2, and TRβ3, that result from
three different transcription start sites [29,30]. The TRΔβ3 form does
not contain the DNA-binding domain and behaves as an inhibitor of
the three TRβ and TRα1 receptors [30,31]. It is worth noting, however,
that TRβ3 and TRΔβ3 have only been described in the rat genome
[31]. TRβ1 displays a ubiquitous expression and is the main TR
isoform that is expressed in the liver. The expression of TRβ2 is
restricted to the pituitary gland, the TRH neurons of the hypothala-
mus, the developing retina, and the inner ear. TRβ3 is present in the
liver, the kidneys, and the lungs, and TRΔβ3 is present in the skeletal
muscles, the heart, the spleen, and the brain [29,31].
From a molecular point of view, TRs heterodimerize with retinoid
X receptors (RXRs) and bind to T3 response elements that are located
within the genomic regions of target genes. In the absence of T3, TRs
interact with co-repressor proteins to inhibit positively regulated
target genes. Following T3 binding, co-repressors are displaced and
co-activator proteins are recruited to the ligand-bound TR complex to
facilitate T3-dependent activation of the target genes. Importantly,
some genes, including thyroid-stimulating hormone (TSH), are
inhibited by T3-liganded TR; however, the mechanism that underlies
the T3-dependent repression of gene transcription is still poorly
understood [2].
2. Intestinal physiology
Formany years, the intestine has been described as an organ target
of TH action [32]. The ﬁrst evidence for a role of these hormones as key
regulators of gastrointestinal development came from observations of
the amphibianmetamorphosis at the beginning of the 20th century. In
fact, metamorphosis is strictly and exclusively controlled by TH, and
during this process, the gastrointestinal tract undergoes a dramatic
remodeling, which includes a ﬁrst phase of apoptosis and,
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focusing ﬁrst on the intestinal postnatal development in mammals
have also unveiled a key role of TH [32]. Interestingly, in mammals, TH
and TR play an important function in both development and in the
homeostatic control of this organ [35,36]. Then, for the speciﬁc aim of
this review, we will focus on the intestinal physiology of amphibians
and mammals.
2.1. Adult functions
The function of the digestive system, which is essentially similar in
all vertebrates, is to digest nutrients as source of energy. As a result,
high and low vertebrates share morphological similarities in the
organization of their gastrointestinal tract and its associated digestive
glands (i.e., the liver and pancreas). However, differences in this
organization exist in accordance with the animal's diet.
The intestine is characterized by a tubular morphology along its
proximodistal axis and is composed of three layers. The outer layer is
the serosa, which contains smooth muscles that are organized in a
circular–inner and in a longitudinal–outer layer. These muscles are
responsible for peristalsis, which is regulated by the parasympathetic
nervous system. The middle layer is the submucosa that consists
of ﬁbrous connective tissue. The inner surface is constituted of
the epithelium, which is organized as a sheet of polarized columnar
cells [37].
The intestinal epithelium is specialized to process and absorb
nutrients and to compact stool. The absorptive surface of the small
intestine (SI) is dramatically increased by numerous protrusions into
the lumen and by invaginations into the submucosa (villi and crypts of
Lieberkühn in mammals, respectively; Fig. 3). The protrusions
generally consist of three differentiated cell types: i) the absorptive
enterocytes; ii) the mucus-secreting goblet cells; and iii) the
enteroendocrine cells, which are scarce and secrete digestive
hormones. In the mammalian intestine, a fourth cell type is alsoFig. 3. Organization of the adult mammalian small intestine. The picture illustrates the
mucosal structure and the different epithelial cell types. The intestinal epithelium is
organized into proliferative compartments (the crypts) and differentiated compart-
ments (the villi). In crypts, somatic stem cells are present, which self-renew and give
rise to undifferentiated progenitors that proliferate, differentiate while migrating, and
are eventually shed in the lumen after apoptosis.present, the Paneth cell. This cell type is present only in the SI, resides
at the bottom of the crypts, and provides antimicrobial peptides [38].
The colon has structural differences compared with the SI. For
example, the intestinal epithelium is ﬂat (i.e., surface epithelium)
and there are no Paneth cells. Nevertheless, we can assume that the
modular organizations of the epithelia of the SI and the colon are
comparable [39].
The intestinal epithelium is a very dynamic, continuously renew-
ing tissue; its homeostasis involves several processes and the
integration of several signaling pathways. This renewal is maintained
by the presence of a proliferative compartment that is located in the
interfold regions of the intestine, where the stem cells are located. In
mammals, these regions are deﬁned as crypts of Lieberkün [40], and
the stem cells reside near their bottom. As summarized in Fig. 3, these
cells self-renew and give rise to the proliferative progenitors that
differentiate as they migrate along the crypt–villus/crypt–surface of
the epithelium axis. Finally, these cells are exfoliated into the lumen
after death at the tip of the villi/surface of the epithelium [39,40].
In amphibians, the adult epithelium renews along the trough–
crest axis of the intestinal folds, with a mechanism that is similar to
that for the mammalian crypt–villus axis [41]. Stem cells have also
been described in the adult amphibian epithelium, residing in the
interfold regions. Similar to the mammalian intestine, these cells give
rise to proliferating progenitors that differentiate, migrate, and die.
At the molecular level, continuous renewal depends on the ﬁne
cross-regulations between several pathways, including WNT/β-
catenin, Hedgehog, Notch, BMP, and TH [36,39,41,42]. These pathways
are considered to be key players in intestinal development and
homeostasis, and the molecular basis of their action has begun to be
characterized in both mammals and amphibians [36,42,43]. However,
the precise mechanisms of the intra- and inter-regulation that occurs
between the signaling pathways and their speciﬁc functions and
activations in different species, have not yet been identiﬁed.
TH signaling, which is the speciﬁc focus of this review, controls the
proliferation of the intestinal epithelial progenitors during the
postnatal maturation steps in both amphibians and mammals.
Moreover, this process is strongly correlated with a set of common
regulated TH-target genes and signaling pathways [36]. However,
discrepancies also exist when comparing these two models. In
particular, the stimulation of cell proliferation by TH in the mouse
intestine principally involves the Wnt/β-catenin pathway, whereas
this pathway does not appear to play a central role in Xenopus.
Moreover, there is very little evidence that TH controls the Wnt/
β-catenin pathway during amphibian intestinal remodeling [43].
Another example of a discrepancy between these two models is the
regulation of Hedgehog by TH. This pathway is essential to maintain
the crypt–villus homoeostasis in mice [41] and is considered one of
the ﬁrst targets of TH in tadpoles [44]. However, the results of a
transcription proﬁle analysis in mouse intestinal crypts have
suggested that there is only a marginal regulation of Hedgehog [45].
These examples clearly illustrate that more work is needed using
these animal models. Increasing the body of knowledge in this speciﬁc
area will help to deﬁne the molecular basis of developmental
abnormalities and of diseases such as cancer.
3. Role of the thyroid hormones and the TRs in the intestine
3.1. Intestinal development
In this section, wewill summarize themost recent advances on the
role of the THs and TRs in intestinal postnatal maturation in tadpoles
and mice. Because the ﬁrst detailed analysis was originally performed
in amphibians during metamorphosis, we will begin by reviewing the
data that have been collected using this vertebrate. Next, we will
review the data concerning mouse intestine maturation at weaning as
well as its homeostatic control.
Fig. 4. Structural changes of the intestine during postnatal development. Pictures
summarize the correlation between the endogenous TH level and i) the intestinal
remodeling during amphibian metamorphosis (lower panel), and ii) mouse postnatal
development (upper panel). Increasing levels of TH characterize the metamorphosis
climax. The tadpole intestinal epithelium undergoes dramatic remodeling until it
reaches an organized compartmentalization that is typical of the frog intestine (lower
panel). During postnatal development in the mouse, the intestinal epithelium
completes the ﬁnal steps of its maturation. Crypt formation and extensive growth are
modulated by several factors, including THs (upper panel).
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Amphibian metamorphosis is a biological event that includes
morphological, biochemical, and cellular changes that occur during
postnatal development. During metamorphosis, tadpoles adapt from
an aquatic to a terrestrial life. This process is obligatorily initiated and
is sustained by a surge in the production of circulating TH [46,47].
Similar to mammals, the TH production in amphibians is under the
control of the hypothalamic–pituitary–thyroid axis (Fig. 1). Secretion
of thyroid-stimulating hormone (TSH) from the pituitary gland occurs
at the onset of metamorphosis and signals the beginning of this
developmental program [48].
Each tissue and organ of the tadpole responds differently to TH. De
novo morphogenesis (i.e., members, jaws, and lung), tissue re-
structuring (i.e., of the skin and the intestine), and extensive cell
death (i.e., in the gills and the tail) occur in response to TH, according
to speciﬁc developmental programs [47,49,50]. From a molecular
point of view, these changes occur in parallel to the altered gene
expression. Both tissue-speciﬁc and generalized TH-dependent
transcriptional programs have been described. In fact, when compar-
ing the transcription proﬁle of several organs during TH-induced
metamorphosis, only a limited number of common TH-target genes
has been reported. The largemajority of these genes, however, display
a tissue-speciﬁc regulation [43].
Amphibians may undergo varying degrees of metamorphic
changes during their postnatal development. The order Anura
shows the most dramatic larva/adult transformation [49]. The Anuran
Xenopus laevis provides the most comprehensive model for under-
standing TH signaling during intestinal postnatal development
[33,51]. During this process, the digestive tract is dramatically re-
built to ﬁt from an herbivorous to a carnivore diet.
The tadpole intestine is a simple lined tube with a monostratiﬁed
epithelium of endodermal origin, which is surrounded by connective
tissue and two muscle layers, the radial/internal layer and the
longitudinal/external layer [52]. Unlike in mammals, there are no
villi and there is only one involution, which is along the ﬁrst third of
the intestine and is called the typhlosole (Fig. 4) [53]. Interestingly,
the intestinal epithelium is renewed by differentiated cells that are
able to proliferate and are randomly distributed [34]. Gut remodeling
occurs when endogenous TH concentration is at its highest level,
which is referred to as the metamorphosis climax (Fig. 4). The
tadpole's monolayered epithelium becomes temporarily heaped into
multilayers by the shortening of the intestine and the constriction of
the intestinal diameter [54]. At this time, the extracellular matrix
proteins of the lamina propria, which are located between the
epithelial and mesenchymal cells, become thicker and more perme-
able. This thickening of the lamina propria allows the larval epithelial
cells to lose their contact with the matrix proteins, inducing their
death by apoptosis. At the same time, the permeability acquired by
the lamina protects a few cells from apoptosis by establishing contact
with the subepithelial ﬁbroblasts. Adult epithelial cell proliferation
increases transiently during metamorphic climax, and this increase is
part of the remodeling process [34]. It has been long disputedwhether
the adult epithelium forms from undifferentiated larval epithelial cells
or from their de-differentiation [54]. By the end of climax, the
muscular and connective tissues are well developed, and the
epithelium is organized in a monolayered sheet of cells. However,
the structure of the epithelium is now more complex and is highly
folded into ridges and troughs that more closely resemble the
anatomy of a mammalian intestine. Moreover, the differentiated
cells are located in the folds, whereas the proliferative cells are located
in the interfold regions. At this point, the epithelium is constantly
being renewed along the trough–crest axis [34]. It is important to note
that the connective tissue plays a key role in the development of the
adult epithelium [55]. As already mentioned, the whole process of
intestinal remodeling is triggered by TH both in vivo [56] and in vitro
[55]. Previous studies have also demonstrated that TRβ is the receptorthat is principally involved in TH-induced metamorphosis. For
example, the level of TRβ expression increases in the tadpole after a
surge of circulating TH [24], and its expression varies according to
their levels [49]. Moreover, studies on both tadpoles [57] and larval
epithelial cells in vitro [24] indicate that TH controls TRβ expression.
On the other side, an essential role of TRα during amphibian
metamorphosis and intestinal remodeling has been reported. TRα is
constitutively and ubiquitously expressed in all organs and tissues of
tadpoles, and its expression proﬁle does not signiﬁcantly change
during metamorphosis [58]. Nevertheless, Schreiber et al. [46]
demonstrated that tadpoles that express a dominant negative form
of TRα are TH-resistant and do not undergo metamorphosis-
dependent intestinal remodeling. Lastly, the mechanism through
which TH controls the expression of TRβ is still unclear. The most
intriguing suggestion is that TRα might be involved in the early
activation of TH direct target genes, including TRβ, because of the
presence of a TRE in its promoter [24,59,60].
3.1.2. Postnatal maturation in mammals
The mouse embryonic gut tube is composed of a pluristratiﬁed
endoderm, which gives rise to a monolayered epithelium, and of a
mesenchyme, which generates the connective and smooth muscle
tissues [61]. The developmental changes that occur during the
endoderm-to-intestinal epithelium maturation are achieved through
major morphogenetic steps that lead to the remodeling of the
primitive gut: i) villus formation during fetal life; ii) crypt formation
after birth; and iii) maturation at weaning, which allows the animal to
adapt from milk to a solid diet [32]. The postnatal events of intestinal
maturation are shown in Fig. 4.
Although several data emphasize the autonomous developmental
properties of the gut, it is well known that its preweaning
development also depends on various growth and hormonal factors
[32]. A role for THs has been suggested during intestinal postnatal
maturation at weaning in rodents because the circulating concentra-
tions increase signiﬁcantly during the second postnatal week (Fig. 4)
[62]. At that time, structural and functional remodeling takes place,
and TH stimulates extensivemucosal growth and initiates the onset of
adult-type digestive enzymes of the absorptive enterocytes [32].
However, only limited data have described the function of TH in adult
intestinal physiology, including metabolic processes such as the
absorption and secretion of nutrients [32,63,64]. The functions of TH
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clariﬁed.
The generation of animal models has provided great insights into
our understanding of the function of TH and TRs in the intestine. These
models represent powerful tools to study and characterize the
molecular mechanisms through which the TH pathway affects
postnatal intestinal development. These animal models have also
enabled us to deﬁne the speciﬁcity of each TR isoform. It is worth
pointing out that almost all of the TR isoforms are expressed by
intestinal epithelial cells [28,65]. The intestine from different TR
knockout animals and from themodels of congenital or induced hypo-
and hyperthyroidism have been analyzed to reveal histological,
proliferation, and differentiation defects in the epithelial cells.
Furthermore, this analysis has been performed on animals aged 2–
3 weeks to recapitulate the maturation process at weaning. This
comparative study led to the following conclusions:
1. TH controls the proliferation of epithelial progenitors during the
maturation at weaning. This function depends on the TRα1
receptor [28,66,67] and involves the regulation of cell cycle control
genes and of the Wnt/β-catenin pathway [45,68] (detailed in the
next section);
2. There is no functional redundancy between the TRα and the TRβ
genes [65];
3. The TRΔα isoforms negatively control epithelial cell proliferation
and differentiation. This results from their repressor activity,
independent of TH, on the Cdx1 and Cdx2 genes [28,65]. The
products of these homeobox genes speciﬁcally control intestinal
epithelial proliferation and differentiation [69];
4. The different effects of the TRα isoforms depend on the level of
their respective expression. For instance, the TRΔα proteins are
destabilized by the TRα1 receptor through a mechanism involving
their degradation by the proteasome pathway [67]. On the other
hand, the TRα1 receptor responsiveness to T3 can be blocked by
the TRΔα proteins [28].
Together, these observations strongly suggest that the different
isoforms encoded by the TRα gene interact during intestinal
maturation at weaning. Their expression has to be strictly controlled
to guarantee normal mucosa growth and functionality. It is worth
noting, however, that only for the Cdx homeobox genes data is
available concerning their complex regulation by the different TRα
isoforms [28,65]. Regarding other intestinal transcription factors such
as β-catenin/Tcf or Notch, key players of intestinal physiopathology
[42], we cannot exclude similar mechanisms of complex regulation.
3.2. The intestinal epithelium stem cells
The intestinal epithelium is characterized by rapid and continuous
renewal throughout life. This renewal process depends onmultipotent
stem cells that are located in speciﬁc compartments [40,54]. According
to Sancho et al. [42], intestinal stem cells are characterized by i) their
retention of an undifferentiated phenotype, ii) their continuous
production of all cell lineages, iii) their self-maintenance capabilities
throughout life, and iv) their ability to regenerate the whole
epithelium after injury.
The role of TH in intestinal epithelium stem cell development and/
or biology has been described only recently, and we mainly rely on
data from amphibians [41,70]. The potential role of TH in the
mammalian stem cell counterpart is for the moment only a
challenging biological question. However, data already exist that
support the involvement of the TRα gene in controlling the
maintenance of neuronal stem cells [71].
TH-dependent intestinal remodeling in amphibians [47,49,50] has
offered a unique opportunity to study the origin and the mechanisms
of organ-speciﬁc adult stem cell development in a vertebrate model.
This is a poorly understood process with important implications instem cell biology, tissue replacement, and regeneration therapy. In the
Xenopus laevis intestine before metamorphosis, all of the epithelial
cells are differentiated cells, as assessed by morphological observa-
tions [53]. Clearly undifferentiated cells appear during metamorpho-
sis; they actively proliferate and their descendents differentiate into
adult epithelial cells [54]. This observation strongly suggests that
there is de novo generation of stem cells during metamorphosis that,
in a similar manner to mammalian stem cells, are responsible for the
maintenance of the adult epithelium [70]. Using transgenic Xenopus
tadpoles and the approach of tissue-recombined organ cultures, the
laboratory of Shi has provided direct evidence that, in fact, stem cells
originate from the larval epithelium through a mechanism of de-
differentiation that is induced by a surge in TH levels. Such stem cells
express Sonic hedgehog [44,72], Musashi-1 [73], a phosphorylated
form of phosphatase and tensin homolog (PTEN), and Akt [51], which
are all candidate markers for mammalian intestinal stem cells [74–
76]. This work demonstrated for the ﬁrst time in a vertebrate that
differentiated cells, after the application of speciﬁc stimuli, can adapt
to respond to developmental constraints.
The epithelial stem cells in the mammalian intestine are still
poorly characterized. In fact, bona ﬁde markers of these cells have
just been described, and well-adapted culture systems, as existing
for amphibians, have been recently developed [39,77–80]. In
addition, the identiﬁcation and characterization of these stem cells
have also been controversial [81,82]. However, it has become clear
that there exist two populations of stem cells. One population is
composed of columnar basal cells (CBCs) at the very bottom of the
crypts between the Paneth cells in the SI. This population cycles
actively, speciﬁcally expresses the Lgr5 marker, and gives rise to the
different cytotypes of the intestinal epithelium. The second
population is composed of quiescent stem cells, which are located
at the +4 position and express Bmi1. This population also gives rise
to all of the epithelial cytotypes, but these cells are slow cycling and
retain labeling. It is not clear at the moment whether there is a
physiological link between these two populations of stem cells.
However, when the Bmi1-expressing cells are experimentally
targeted in vivo by the diphtheria toxin, there is also a depletion
of the CBC cells, suggesting a hierarchy between the two popula-
tions of stem cells [83]. Given that an analogous observation has not
been reported for the Lgr5-expressing cells, we cannot deﬁnitively
conclude on that subject.
Undoubtedly, the ﬁndings from the frog model will improve our
basic understanding of organ-speciﬁc adult stem cell development. In
light of the results in amphibians, we can reconsider the results from
the previous studies of intestinal regeneration in the mammal
intestine. Using clonogenic assays, the laboratory of Potten has
shown that, after the experimental removal of the stem cells by
radiation, the epithelium still maintains the capability to regenerate.
This capability is due to the presence of committed progenitors in the
crypts, called epithelial transit cells. After experimental injury, these
cells de-differentiate into stem cells, which then regenerate the
whole intestinal epithelium [84,85]. In this regard, these epithelial
transit cells may resemble the tadpole intestinal epithelial cells,
which are differentiated but mitotically active. Thus, the ability to
reverse from the differentiated state to the stem cell state may be a
characteristic of these epithelial cells that is conserved in the
mammalian and amphibian intestine. However, in the case of the
mammalian system, the stimuli and signals that are necessary to
begin de-differentiation are not clearly deﬁned. Therefore, it is worth
speculating on the possible involvement of TH and TR in stem cell
physiology, considering the fact that TRα0/0 mice exhibit a low
regeneration rate in the intestinal epithelium after radiation-induced
injury [35].
Currently, we have no speciﬁc data concerning stem cell origins
and/or selection in the mammalian intestine. In our opinion, the RNA-
binding proteinMusashi-1, which has also been proposed to be a stem
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suitable candidate marker to study the stem cell's peculiarities in
these models [73,75]. In fact, it has been shown that, in both
amphibians and mammals, the expression of Musashi-1 may be
under the control of TH [73,86]. Although more work is needed, it is
clear that Musashi-1 links stem cell and tumor biology through its
functional relations with the Wnt, Notch, and TH signaling pathways
[86]. Similar observations are not yet available for the other bona ﬁde
stem cell markers.
Altogether, the ﬁndings provided from the frog model and the ﬁrst
ﬁndings inmammals substantially improve our basic understanding of
this organ-speciﬁc adult stem cell development and physiology. They
will surely contribute valuable information for regenerative medicine
of the digestive tract and for cancer stem cell targeted therapy.
4. From development to cancer: TR (de)regulation
The process of intestinal maturation and its homeostatic control by
TH–TRα1 in mice results from a complex modulation of genes and
signaling pathways. In this section, we summarize data concerning
the regulation of the Wnt/β-catenin and other signaling pathways
involved in intestinal homeostasis by TRα1. These data led to a new
perspective in the study of TRα1 as a tumor-inducer in the
gastrointestinal tract (Fig. 5). Indeed, we also describe recent results
of our study on a speciﬁc mouse model, demonstrating for the ﬁrst
time the involvement of TRα1 in intestinal tumorigenesis.
4.1. Crosstalk between TR and other signaling pathways
We have shown that TH signaling in the mouse intestine leads to
the activation of cell proliferation, and its action is speciﬁcally
mediated by TRα1. Detailed analyses in vivo and in vitro have
demonstrated that this is due, at least in part, to the activation of the
WNT pathway [45,68]. This pathway is considered a key signaling
modulator of physiological and pathological cell proliferation in the
intestinal epithelium [87]. Moreover, due to its direct action on
epithelial stem cells, it is also a main regulator of epithelial
homeostasis [87]. The extracellular Wnt signal is transduced by its
binding to the transmembrane frizzled receptor, resulting in the
stabilization of β-catenin (the intracellular mediator of Wnt) and the
activation of Tcf/β-catenin target genes [88]. Our studies have shown
that the TRα1 receptor is a direct transcriptional regulator of several
components of the Wnt pathway. In intestinal epithelial progenitors,
TH–TRα1 increases the level of expression of both β-catenin and
secreted frizzled-related protein-2 (sFRP2). Increased levels of the
sFRP2 protein in the extracellular milieu allow stabilization of β-
catenin, resulting in the increased expression of the Wnt targetFig. 5. Correlation between gene deregulation and intestinal tumorigenesis. The picture
tumorigenesis in human. Apc gene mutation, which is responsible for Wnt/β-catenin over-a
other indicated mutations are more frequently associated with the later stages. Although
accepted that the accumulation of multiple genetic alterations is the key element in tumor
(early or late) TRα1 is involved in intestinal tumorigenesis. LOH indicates loss of heterozyggenes and in the stimulation of epithelial progenitor proliferation
[45,68].
To explore in more detail the effect of TH signaling in the mouse
intestine in vivo, we have used a global comparative transcription
proﬁle approach on laser microdissected intestinal crypt cells. This
study allowed us not only to compile a comprehensive list of the TH-
target genes in the proliferative compartment but also to deﬁne the
crosstalk between TH–TRα1 and other signaling pathways in the
control of epithelial cell homeostasis [45]. The results of our analysis
has indicated that, in addition to Wnt, also Notch and BMP, other key
signaling pathways involved in intestinal development and homeo-
stasis [89], are regulated by changes in TH levels [45]. As shown in
Fig. 5, intestinal tumorigenesis results from mutations and epigenetic
events that deregulate these same pathways [42,79,88,90,91]. These
observations strongly suggested that TRα1 has a tumor-inducing
potential.
4.2. The role of TRs in intestinal tumorigenesis
Several reports have indicated that mutant TRs and altered TH
statuses are involved in various cancers [12,92–96]. Data have shown
that a correlation exists between altered levels of TH and the
development of human breast and colon cancers [94,96]. However,
discrepancies in the literature exist, and both increased and decreased
levels of hormones have been reported. Concerning the TRs, it has
been shown that the mutation [95,97,98] or the aberrant expres-
sion [92] of TRs is associated with gastrointestinal tumors. However,
no conclusive evidence exists that links the pro-proliferative action of
TRs to tumorigenesis.
In an effort to understand whether the TRα1 receptor may be
involved in intestinal tumorigenesis, we recently developed a mouse
model characterized by an intestinal epithelium-targeted overexpres-
sion of TRα1. As expected, this overexpression induced intestinal
progenitor hyperproliferation and caused adenoma development in
both the small intestine and the colon [99]. Although this over-
expression is unable to trigger a complete adenoma–carcinoma
sequence per se (Fig. 5), we reported an accelerated rate of tumor
appearance, tumor progression, and liver metastasis dissemination
after overexpressing TRα1 in Apc+/1638N mice, which are genetically
predisposed to develop intestinal cancer [100,101]. Until now,wehave
described c-Fos up-regulation as the major molecular feature of these
TRα1-overexpressing mice (in both healthy mucosae and in lesions).
This proto-oncogene has already been reported to be a TH-target in
vivo [45], but it is not directly controlled at the transcriptional level
(our unpublished observation). TRs can interact with other transcrip-
tion factors, including c-Fos, and these interactions modulate the
transcriptional activity of the players involved [93,102–104]. Then, asummarizes the sequential genetic alterations frequently associated with colorectal
ctivation, is the key event that occurs during the early stage of cell transformation. The
these mutations may be speciﬁcally representative of a tumoral stage, it is generally
progression [110]. Our aim is to understand how and when in that sequence of events
osity.
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intestine should also take into account this level of cross-regulation.
Previous work suggesting a tumor-inducing role of TRs focused on
mutated forms of TR that act as dominant negatives and are
independent of TH binding. The novelty of our approach and results
is the demonstration that the speciﬁc overexpression of the TRα1
receptor in vivo is able to trigger hyperproliferation and to accelerate
the tumorigenic process in animals that are susceptible to developing
intestinal cancer.
5. Concluding remarks
For almost a century, TH and amphibian metamorphosis repre-
sented a key system for developmental biologists. This model has
been used to study biochemical and morphological changes associ-
ated with organogenesis and tissue remodeling in animals during
postnatal development [24,50]. This classical system is, however, still
of actuality and useful to investigate intestinal physiology and
eventually pathological events. Despite the data on amphibians, the
studies of mammal intestinal postnatal development are quite recent.
Nevertheless, they have shown that TH plays a key role in controlling
intestinal epithelial progenitor proliferation through the TRα1
receptor. Moreover, after comparing the molecular processes of
intestinal development that are modulated by TH in tadpoles and
mice, we observe similarities in the structural and molecular changes
[36,41,43]. We strongly believe that the comparative analysis of the
two models will yield further insights into these processes as well as
into intestinal stem cell development and physiology. However,
when we also consider the discrepancies that result from this
comparison, we can hypothesize that we still need to develop a more
suitable comparative approach, which would take into account
homologous stages and/or developmental conditions. Finally, the
involvement of TH–TR signaling in tumorigenesis is still poorly
understood. We have demonstrated for the ﬁrst time that the
overexpression of a non-mutated TR receptor may be involved in
tumorigenesis. Our next challenge will be to test whether TRα1
overexpression is related to human colorectal cancer, which, if this
proves to be the case, will create new avenues for translational
research. In fact, by developing TR-isoform-speciﬁc agonists or
antagonists, we could use them for targeted therapies. However,
TRα1 speciﬁc antagonists are not yet available, despite their potential
applications to treat arrhythmias or in preventing bone loss [105]. On
the contrary, speciﬁc agonists for TRβ1, such as GC-1 and KB2115
[106,107], have been developed and show beneﬁc effects on
cholesterol and lipid metabolism, without the side effects typical of
T3 on the heart and skeleton [108,109]. Then, taking into account our
recent studies demonstrating the involvement of TRα1 receptor in
gut tumorigenesis, speciﬁc TRα1 antagonists could prove of use to
down-regulate its activity in human tumors.
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